WA research brings hope for tackling rare neurological disorders in children
A severe genetic disorder known as Angelman syndrome (AS) is one of three rare conditions targeted in WA research receiving...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
Research group
Olia is a PhD candidate with a background in chemistry and biochemistry. She is also familiar with different methods of nanoparticle synthesis. Her project focuses on fabricating a nanocarrier that can cross therapeutic agents through the blood-brain barrier, delivering them to the damaged brain cells and releasing them at the target site in Alzheimer’s disease. She hopes to overcome the difficulty in treating brain disorders and remove concerns about increasing their number worldwide.
Keep informed with our latest updates.
Stay up to date with our latest news and announcements.